Priyanka Pophali

13PUBLICATIONS
79CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Rural and remote health servicesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 16, 2026
Palliative care and hospice utilization in patients with relapsed or refractory diffuse large B-cell lymphoma in the era of CART and novel immunotherapies.

|Feb 27, 2026
Cancer Survivorship Practices Among Cancer Care Providers and Cancer Centers in Brazil: Results From a National Survey.

Cibele Barbosa Carroll, Juliana Ribeiro de Carvalho, Ana Luiza Cardona Miranda Machado

|Feb 24, 2026
Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma.

Yucai Wang, Melissa C Larson, Steven R Hwang

|Dec 11, 2025
Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma.

Yucai Wang, Melissa C Larson, Steven R Hwang

|Dec 10, 2025
Bridging the Gap: Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma: Long-Term Benefit, Yet Real-World Complexity.

Priyanka A Pophali, Vaishalee P Kenkre, Christi Ann Hayes

|Jul 15, 2025
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab.

Taylor R Brooks, Emily C Zabor, Yohanna B Bedelu

Pageof 3

Frequent Collaborators

4 joint publications

Natalie S Grover

4 joint publications

Matthew J Maurer

4 joint publications

Reem Karmali

3 joint publications

Muhamad Alhaj Moustafa